Clinical Decision Support System for Diabetes Based on Ontology Reasoning and TOPSIS Analysis

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Class</td><td class="align_center">Description</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Glucose-Lowering_Agents</td><td class="align_center">Concepts are glucose-lowering drugs. Ontology content is based on the ADA/EASD’s position statement on management of hyperglycemia in type 2 diabetes to be established</td></tr><tr><td class="align_left">Glucose-Lowering_Advantages</td><td class="align_center">Concepts about glucose-lowering advantages</td></tr><tr><td class="align_left">Glucose-Lowering_Cellular_mechanisms</td><td class="align_center">Concepts about glucose-lowering cellular mechanisms</td></tr><tr><td class="align_left">Glucose-Lowering_Compounds</td><td class="align_center">Concepts about glucose-lowering compounds</td></tr><tr><td class="align_left">Glucose-Lowering_Cost</td><td class="align_center">Concepts about glucose-lowering cost</td></tr><tr><td class="align_left">Glucose-Lowering_Disadvantages</td><td class="align_center">Concepts about glucose-lowering disadvantages</td></tr><tr><td class="align_left">Glucose-Lowering_Primary_physiological_actions</td><td class="align_center">Concepts about glucose-lowering primary physiological actions</td></tr><tr><td class="align_left">Patients</td><td class="align_center">Concepts about patient’s profile, the properties include patient’s adverse drug reactions (ADRs) and history of diseases</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Journal of Healthcare Engineering

tab5

Table 5

Table 5: Clinical Decision Support System for Diabetes Based on Ontology Reasoning and TOPSIS Analysis 